Acción AUTL AUTOLUS THERAPEUTICS PLC
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Autolus Therapeutics plc

Acciones

AUTL

US05280R1005

Tiempo real estimado Cboe BZX
Otros sitios de cotización
 15:33:29 01/07/2024 		Varia. Cinco días. Varia. 1 de enero.
3,415 USD -1,87 % Gráfico intradía de Autolus Therapeutics plc -9,14 % -45,96 %
28/06 La renta variable europea cotiza en EE.UU. con recibos de depósito estadounidenses al alza en la sesión del viernes MT
21/06 La renta variable europea negociada en EE.UU. como recibos de depósito estadounidenses tiende a la baja el viernes pero termina la semana al alza MT

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Friday Trading
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
Autolus Therapeutics plc to Present Three Clinical Data Updates on Obecabtagene Autoleucel (obe-cel) in Relapsed/Refractory B-Cell Acute L-Cell Acute Lymphoblastic Leukemia Patients at the 2024 European Hematology Association Congress
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading
Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL in an oral presentation at ASCO
Autolus Therapeutics plc Presents Long-Term Follow-Up and Additional Data Analysis of Pivotal Phase 2 FELIX Study of Obecabtagene Autoleucel in an Oral Presentation at ASCO
Tech Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading
Syncona notes Autolus's first quarter loss widens amid higher costs
Sector Update: Health Care Stocks Steady Pre-Bell Friday
Exchange-Traded Funds, Equity Futures Tread Water Pre-Bell Friday Amid Waning September Rate Cut Hopes
Autolus Therapeutics' Q1 Loss Widens, Licensing Revenue Rises
Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
Autolus Therapeutics plc Reports Earnings Results for the First Quarter Ended March 31, 2024
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción AUTL
  4. Noticias Autolus Therapeutics plc
  5. Otros idiomas